Source: ACADIA Pharmaceuticals Inc. ACADIA Pharmaceuticals Inc. Uli Hacksell, Ph.D., Chief Executive Officer Thomas H. Aasen, Executive Vice President, Chief Financial Officer and Chief Business Officer 858-558-2871

AcAdiA PhArmAceuticAls | 2013 AnnuAl rePort 1 Uli Hacksell, Ph.D. Chief Executive Officer Q. For ACADIA, 2013 was a transformational year. What stands out most? A. In 2013, we made impressive progress toward our ultimate goal of bringing innovative medicines like pimavanserin, our most advanced product candidate, to market "We are delighted to complete this financing with such an outstanding syndicate of investors," said Uli Hacksell, Ph.D., ACADIA's Chief Executive Officer. Source: ACADIA Pharmaceuticals Inc. ACADIA Pharmaceuticals Inc. Uli Hacksell, Ph.D., Chief Executive Officer Thomas H. Aasen, Executive Vice President, Chief Financial Officer and Chief Business Officer 858-558-2871 Uli Hacksell CERC stock SEC Form 4 insiders trading. Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Uli bought 20,000 units of CERC stock worth $15,000 on 10 December 2016.

Uli hacksell acadia pharmaceuticals

Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders. “Uli Hacksell has tremendous experience of scaling life science companies and is highly regarded for his broad knowledge based on his past leading positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Uli Hacksell This page shows the track record and history of Hacksell Uli insider trades in ACADIA Pharmaceuticals, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. Som vd för ACADIA Pharmaceuticals 2000-2015 ledde Hacksell utvecklingen från privat start-up företag till publikt mångmiljardbolag. Innehade under 90-talet ledande befattningar inom Astra AB. Var dessförinnan professor i organisk kemi vid Uppsala universitet. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 6, 2014 5:00 PM ET Executives.

Som vd för ACADIA Pharmaceuticals 2000-2015 ledde Hacksell utvecklingen från privat start-up företag till publikt mångmiljardbolag. Innehade under 90-talet ledande befattningar inom Astra AB. Var dessförinnan professor i organisk kemi vid Uppsala universitet.

Uli Hacksell har styrelseuppdrag i Medivir, Index Pharmaceuticals Holding, 9 juli 2015 - InDex Pharmaceuticals meddelade idag att Uli Hacksell och Jesper Han var VD för amerikanska ACADIA Pharmaceuticals från Sverige slog Danmark i kampen om amerikanska Acadia Pharmaceuticals kemiforskning. Acadias vd Uli Hacksell (mitten) i labbet tillsammans med Anne Att Acadia, med huvudkontor och biologiforskning i San Diego på Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i istället till det danmarksbaserade biotechföretaget Acadia Pharmaceuticals. Chef för Global Clinical R&D och Senior Vice President på Celgene.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 6, 2014 5:00 PM ET Executives. Lisa Barthelemy - Director of Investor Relations. Uli Hacksell - CEO. Roger G

ACADIA Pharmaceuticals Inc. uses 4 email formats: 1. first_initial ACADIA Pharmaceuticals Inc.'s Email Format, Percentage Uli Hacksell's profile photo. I, Uli Hacksell, Ph.D., certify that: 1. I have reviewed this annual report on Form 10 -K for the year ended December 31, 2006 of ACADIA Pharmaceuticals Inc. 2. Acadia Pharmaceuticals (NASDAQ:ACAD) stock surged 155 per cent Tuesday successfully met all the objectives of this study," Acadia CEO Uli Hacksell said.

Affiliation. 1 ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA, uli@acadia-pharm.com. PMID: 24682754; PMCID: Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Borrmann, left Acadia to lead Maret Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016. ACADIA Pharmaceuticals Inc. uses 4 email formats: 1.
Hur söker man sommarjobb på ikea

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $62,000 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $62,000 and over the last 17 years Uli … The estimated Net Worth of Uli Hacksell is at least $62 Tysiąc dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $62,000 and over the last 17 years Uli sold CERC stock worth over $0. The estimated Net Worth of Uli Hacksell is at least $61 Тысяча dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0. View Uli Hacksell’s profile on LinkedIn, the world's largest professional community.

Based on CEO Uli Hacksell's Shareholders of SynAct Pharma proposes Uli Hacksell as new board member US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Få den seneste information om ACADIA PHARMACEUTICALS A/S. Se regnskaber, Uli Alf Hacksell stopper som administrerende direktør for ACADIA 6 Nov 2013 "We remain focused on building value in our pimavanserin franchise and advancing our pipeline," said Uli Hacksell, Ph.D., ACADIA's Chief Roxanne Jividen is the Division President at Acadia Healthcare Company based in Acadia Pharmaceuticals CEO Uli Hacksell speaks at the Jefferies 2013 7 apr 2021 Uli Hacksells CV inkluderar 30 års arbete inom farmaceutisk industri och däribland som vd för San Diego-baserade Acadia Pharmaceuticals. Uli Hacksell har styrelseuppdrag i Medivir, Index Pharmaceuticals Holding, .. 4 Sep 2014 Therapy designation to Acadia Pharmaceuticals' Nuplazid (Pimavanserin) for disease psychosis,” said Uli Hacksell, Ph.D., CEO of Acadia.
H index web of science

ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer SAN DIEGO-- ACADIA Pharmaceuticals Inc. (ACAD), a

President and Chief Executive Officer . ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871 (Telephone Number, Including Area Code, of Agent for Service) SAN DIEGO--(BUSINESS WIRE)--Dec. 20, 2012-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will receive funding from Fast Forward, LLC, a not-for-profit organization established by the National Multiple Sclerosis In 2001, the company's chief executive officer at the time, Leonard R. Borrmann, left Acadia to lead Maret Pharmaceuticals.

Varian wrynn

6,5 miljoner kronor till Nasdaq-noterade Acadia Pharmaceuticals, vars Vd:n för bolaget heter sedan åer 2000 Uli Hacksell och är före detta

Total Offering Expense, $1,300,000.00. Shareholder View Uli Hacksell's profile on LinkedIn, the world's largest professional community.

ACADIA Pharmaceuticals (NASDAQ:ACAD) Q4 2013 Earnings Call February 27, 2014 5:00 PM ET. Executives. Lisa Barthelemy - Director of Investor Relations. Uli Hacksell - Chief Executive Officer

“Terry is an exceptional individual who brings a wealth of commercial experience to ACADIA from a variety of senior roles at several leading pharmaceutical companies. "We are delighted to complete this financing with such an outstanding syndicate of investors," said Uli Hacksell, Ph.D., ACADIA's Chief Executive Officer. ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer March 11, 2015 04:02 PM Eastern Daylight Time In 2001, the company's chief executive officer at the time, Leonard R. Borrmann, left Acadia to lead Maret Pharmaceuticals.

ACADIA Pharmaceuticals Inc. 2004 EQUITY INCENTIVE PLAN. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Titles of the Plans) Uli Hacksell, Ph.D. President and Chief Executive Officer . ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard . San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871 ACADIA Pharmaceuticals Inc. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Title of the Plan) Uli Hacksell, Ph.D. President and Chief Executive Officer .